Citation: Km. Radomski et al., COLLABORATION BETWEEN PHARMACY AND LABORATORY - DEFINING TOTAL ALLOWABLE ERROR LIMITS FOR THERAPEUTICALLY MONITORED DRUGS, The Annals of pharmacotherapy, 32(2), 1998, pp. 170-175
Citation: Mhh. Ensom et al., VALIDATION OF THE HARTFORD NOMOGRAM IN TRAUMA SURGERY PATIENTS - AUTHORS REPLY, The Annals of pharmacotherapy, 32(10), 1998, pp. 1109-1109
Citation: Mhh. Ensom et al., CLINICAL PHARMACOKINETICS IN THE 21ST-CENTURY - DOES THE EVIDENCE SUPPORT DEFINITIVE OUTCOMES, Clinical pharmacokinetics, 34(4), 1998, pp. 265-279
Authors:
WOODWARD DK
HATTON J
ENSOM MHH
YOUNG B
DEMPSEY R
CLIFTON GD
Citation: Dk. Woodward et al., ALPHA(1)-ACID GLYCOPROTEIN CONCENTRATIONS AND CEREBROSPINAL-FLUID DRUG DISTRIBUTION AFTER SUBARACHNOID HEMORRHAGE, Pharmacotherapy, 18(5), 1998, pp. 1062-1068
Citation: Cd. Cropp et al., EVALUATION OF AMINOGLYCOSIDE PHARMACOKINETICS IN POSTPARTUM PATIENTS USING BAYESIAN FORECASTING, Therapeutic drug monitoring, 20(1), 1998, pp. 68-72